Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3182980

Documents

Beta release

Statistics of Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W)
Statistics for this year
PeriodVisitsDownloads
20241615
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0811
2024-0933
2024-1000